A review of lower genital intraepithelial neoplasia and the use of topical 5-fluorouracil.
Sillman
F H
FH
Sedlis
A
A
Boyce
J G
JG
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000287:Administration, Topical; D000328:Adult; D001003:Anal Canal / Q000473:pathology; D001005:Anus Neoplasms / Q000188:drug therapy / Q000473:pathology; D002277:Carcinoma / Q000188:drug therapy / Q000473:pathology; D002278:Carcinoma in Situ / Q000188:drug therapy / Q000473:pathology; D002280:Basal Cell Carcinoma / Q000188:drug therapy / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000473:pathology; D002584:Cervix Uteri / Q000473:pathology; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D005833:Genital Neoplasms, Female / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications / Q000151:congenital; D007642:Keratosis / Q000188:drug therapy / Q000473:pathology; D009378:Neoplasms, Multiple Primary / Q000188:drug therapy / Q000473:pathology; D010145:Paget Disease, Extramammary / Q000188:drug therapy; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology; D013577:Syndrome; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000473:pathology; D014621:Vagina / Q000473:pathology; D014625:Vaginal Neoplasms / Q000188:drug therapy / Q000473:pathology; D014844:Vulva / Q000473:pathology; D014846:Vulvar Neoplasms / Q000188:drug therapy / Q000473:pathology
D005472:Fluorouracil